J. Lau

Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy.

J. Mccormack, C. L. Brand, N. Westergaard, 2001, Current pharmaceutical design.

The effects of HDV-insulin on carbohydrate metabolism in Type 1 diabetic patients.

D. Granner, S. Davis, P. Galassetti, 2001, Journal of diabetes and its complications.

Original articles The effects of HDV-insulin on carbohydrate metabolism in Type 1 diabetic patients

D. Granner, S. Davis, P. Galassetti, 2001 .

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

G. Jerums, J. Clausen, M. Cooper, 1999, Diabetologia.